Sudden death associated with a novel H401Q PRKAG2 mutation
Europace
.
2020 Aug 1;22(8):1278.
doi: 10.1093/europace/euaa014.
Authors
Maria Helena Albernaz Siqueira
1
2
,
Kinulpe Honorato-Sampaio
3
,
Glauber Monteiro Dias
4
,
Jon R Wilson
5
,
Arash Yavari
6
,
Geraldo Brasileiro Filho
7
,
Eduardo Back Sternick
1
8
Affiliations
1
Faculdade Ciências Médicas-MG, Belo Horizonte, Minas Gerais, Brazil.
2
Rede Mater Dei de Saúde, Belo Horizonte, Minas Gerais, Brazil.
3
Faculdade de Medicina, Universidade Federal do Vale do Jequitinhonha e Mucuri, Diamantina, Minas Gerais, Brazil.
4
Centro de Tecnologia Celular, Instituto de Cardiologia, Ministério da Saúde, Rio de Janeiro, Brazil.
5
Francis Crick Institute, London, UK.
6
Experimental Therapeutics and Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
7
Department of Pathology, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
8
Arrhythmia Unit, Biocor Institute, Minas Gerais, Brazil.
PMID:
32215636
DOI:
10.1093/europace/euaa014
No abstract available
Publication types
Case Reports
MeSH terms
AMP-Activated Protein Kinases* / genetics
Cardiomegaly
Death, Sudden
Humans
Mutation
Wolff-Parkinson-White Syndrome*
Substances
PRKAG2 protein, human
AMP-Activated Protein Kinases